Drug intelligence / Profile preview

South America anti-snake antivenom

Development stage
Unknown
Lead developer
Inosan Biopharma
Modality
Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

South America anti-snake antivenom is a polyvalent antivenom developed by Inosan Biopharma for the treatment of snake envenomation in South America. It is composed of equine-derived F(ab')2 immunoglobulin fragments, which are produced by the pepsin digestion of IgG from horses immunized with a mixture of snake venoms. This process removes the Fc portion of the antibody to minimize the risk of serum sickness and other adverse reactions. The antivenom works by binding to and neutralizing various toxins found in the venom of South American snakes, such as those from the *Bothrops* and *Crotalus* genera. It is currently in Phase 1 clinical development.

Other names
South America Anti-Snake Antivenom
02

Targets

svPLA2 (Snake venom phospholipase A2)SVMP (Snake venom metalloproteinase)SVSP (Snake venom serine protease)

Beyond the preview

Go deeper on South America anti-snake antivenom.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on South America anti-snake antivenom.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call